Fund manager with 20% gain this year sees good times ahead as FDA becomes ‘more accommodating’
July 13, 2017 at 05:04 AM EDT
Ziad Bakri, manager of the T. Rowe Price Health Sciences Fund, looks for three main themes in his stock picks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|